Showing results (71-80 of 7,836) with videos related to
Sort By:
Pageof 784
Expert Review of Hematology|June 14, 2015
Preclinical and clinical evaluation of elotuzumab, a SLAMF7-targeted humanized monoclonal antibody in development for multiple myelomaAntonio Palumbo, Pieter SonneveldLeukemia|July 1, 1997
Assays for the analysis of P-glycoprotein in acute myeloid leukemia and CD34 subsets of AML blastsP Sonneveld, E WiemerBritish Journal of Haematology|June 1, 1990
Reversal of drug-resistance by cyclosporin-A in a patient with acute myelocytic leukaemiaP Sonneveld, K NooterFood Technology and Biotechnology|July 19, 2019
Multiplex Real-Time PCR with HRM for Detection of Lactobacillus sakei and Lactobacillus curvatus in Food SamplesKonstantin A Kurbakov, Evgenii A Konorov, Mikhail Y Minaev, et al.Leukemia Research|April 1, 1994
Clinical relevance of P-glycoprotein expression in haematological malignanciesK Nooter, P SonneveldExpert Opinion on Pharmacotherapy|August 7, 2015
An update in treatment options for multiple myeloma in nontransplant eligible patientsAnnemiek Broijl, Pieter SonneveldSovetskaia Meditsina|January 1, 1991
[Reflux gastritis in duodenal ulcer]A A Grinberg, T D Kanareĭtseva, O E Kurbakov, et al.Cancer Chemotherapy and Pharmacology|January 1, 1978
The relevance of cell kinetics for optimal scheduling of 1-beta-D-arabinofuranosyl cytosine and methotrexate in a slow growing acute myeloid leukemia (BNML)M Aglietta, P SonneveldBest Practice & Research. Clinical Haematology|November 1, 2003
Immunophenotyping as a guide for targeted therapyPieter Sonneveld, Rob PietersLeukemia Research|November 27, 2012
Disease control in patients with relapsed and/or refractory multiple myeloma: what is the optimal duration of therapy?Heinz Ludwig, Peter SonneveldPageof 784